May 27
B.C. arthritis, diabetes patients have 6 months to switch to cheaper ‘biosimilar’ drugs
British Columbians on certain drugs for arthritis and diabetes will have six months to transition to equivalent less-costly drugs, as the province expands use of “biosimilars.”
The move is expected to save $96 million over the first three years.
Times Colonist